Akums Drugs and Pharmaceuticals Limited
Bandhan Mutual Fund increased its stake in Akums Drugs and Pharmaceuticals to 1.13% from 1.11%, buying 30,100 shares. The value of the additional shares is ₹2 Cr based on the share price of ₹664.95.
A contract development and manufacturing organization that produces pharmaceutical products for domestic and international clients. Established in 2004, Akums Drugs operates across multiple therapeutic areas and dosage forms, providing end-to-end manufacturing solutions including formulation development, clinical trial supplies, and commercial production. The company distinguishes itself through its vertically integrated operations, modern manufacturing facilities, and commitment to quality compliance across all operations.
Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.